These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 45724)

  • 1. The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1977 Mar; 2(4-5):227-32. PubMed ID: 45724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of adriamycin in mice bearing mammary adenocarcinoma 16/C.
    Simpson-Herren L; Noker PE
    Cell Prolif; 1991 May; 24(3):241-55. PubMed ID: 2039801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the toxicity and antitumor activity of adriamycin-DNA and amsacrine-DNA complexes in mice].
    Zhang XG; Wu DZ
    Yao Xue Xue Bao; 1992; 27(11):801-5. PubMed ID: 1300022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type A adenocarcinoma grafted into C3H/he-M mice subjected to treatment with various antineoplastic agents. I. Biological study].
    Flores JM; Gallego E; Castaño M; Gallego A
    Rev Esp Oncol; 1983; 30(3):337-59. PubMed ID: 6571377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic consequences of antitumour drug interactions: methotrexate and 5-fluorouracil in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1978 Nov; 5(5):291-7. PubMed ID: 728887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W
    Strahlenther Onkol; 1991 Sep; 167(9):553-60. PubMed ID: 1925940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
    Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
    Cancer Treat Rep; 1978 Oct; 62(10):1471-88. PubMed ID: 709550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study].
    Flores JM; Gallego E; Castaño M; González JL
    Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo tumor response to single and multiple exposures of adriamycin.
    Siemann DW; Sutherland RM
    Eur J Cancer (1965); 1980 Nov; 16(11):1433-40. PubMed ID: 7227420
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin effects and the interactions of adriamycin with X irradiation on murine mammary tumors.
    Dethlefsen LA; Riley RM
    Radiat Res; 1982 Apr; 90(1):165-72. PubMed ID: 7063633
    [No Abstract]   [Full Text] [Related]  

  • 13. Flow cytometric analysis of adriamycin-perturbed mouse mammary tumors.
    Dethlefsen LA; Riley RM; Roti Roti JL
    J Histochem Cytochem; 1979 Jan; 27(1):463-9. PubMed ID: 374611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin.
    Casas A; Fukuda H; Riley P; del C Batlle AM
    Cancer Lett; 1997 Dec; 121(1):105-13. PubMed ID: 9459181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
    Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
    Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
    Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of [67Ga]citrate and 111InCl3 in mouse with adenocarcinoma.
    Saha GB; Boyd CM
    Int J Nucl Med Biol; 1983; 10(4):223-5. PubMed ID: 6582052
    [No Abstract]   [Full Text] [Related]  

  • 18. Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):375-83. PubMed ID: 8866656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
    Horsman MR; Nordsmark M; Høyer M; Overgaard J
    Br J Cancer; 1995 Dec; 72(6):1474-8. PubMed ID: 8519662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo.
    Overgaard J
    Cancer Res; 1976 Sep; 36(9 pt.1):3077-81. PubMed ID: 975075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.